Methyl 3-Methoxybenzoate

Methyl 3-Methoxybenzoate

SCHEMBL384913

COC(=O)c1cccc(OC)c1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.73
TP53 P04637 3/20 0.73
CES2 O00748 1/20 0.71
CES1 P23141 1/20 0.71
NPC1 O15118 8/20 0.69
RAB9A P51151 8/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
ALDH1A1 P00352 2/20 0.69
PKM P14618 1/20 0.69
HPGD P15428 1/20 0.69
MAPK1 P28482 1/20 0.69
PARP1 P09874 1/20 0.67
POLB P06746 1/20 0.65
BLM P54132 1/20 0.65
ESR1 P03372 1/20 0.65
ESR2 Q92731 1/20 0.65
MAPT P10636 2/20 0.63
LMNA P02545 1/20 0.63
HTT P42858 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl 3-Methoxybenzoate SCHEMBL29702092 1.00 SMN1; SMN2 (0.73) SMN1; SMN2TP53CES2CES1NPC1
SCHEMBL5558318 0.93 SMN1; SMN2 (0.66) SMN1; SMN2TP53CES2CES1NPC1
Methyl 3-Methoxybenzoate SCHEMBL27476346 0.91 SMN1; SMN2 (0.64) SMN1; SMN2TP53CES2CES1NPC1
Methyl 3-Methoxybenzoate SCHEMBL7469145 0.90 SMN1; SMN2 (0.62) SMN1; SMN2TP53CES2CES1NPC1
SCHEMBL6432447 0.89 NEK1 (0.63) SMN1; SMN2TP53CES2CES1NPC1
SCHEMBL30393680 0.88 CES2 (0.71) SMN1; SMN2TP53CES2CES1NPC1
SCHEMBL447346 0.88 CES2 (0.71) SMN1; SMN2TP53CES2CES1NPC1
SCHEMBL23509 0.88 CES2 (0.71) SMN1; SMN2TP53CES2CES1NPC1
SCHEMBL2436534 0.88 L3MBTL1 (0.65) SMN1; SMN2TP53CES2CES1NPC1
Methyl 3-Methoxybenzoate SCHEMBL28299987 0.87 SMN1; SMN2 (0.59) SMN1; SMN2TP53CES2CES1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946240-B1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO KGAA (DE) 2025-10-15 EP claimed
WO-2024182515-A1 AGENTS FOR REPELLING, KNOCKING DOWN, AND/OR KILLING BLOOD-SUCKING ARTHROPODS AND USES THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2024-09-06 WO claimed
US-20240292836-A1 AGENTS FOR REPELLING, KNOCKING DOWN, AND/OR KILLING BLOOD-SUCKING ARTHROPODS AND USES THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 2024-09-05 US claimed
CN-118006054-B Weather-resistant and anti-fouling plastic wallboard and preparation method thereof 浙江奕科新材料股份有限公司 2024-07-23 CN claimed
CN-118006054-A Weather-resistant and anti-fouling plastic wallboard and preparation method thereof 浙江奕科新材料股份有限公司 2024-05-10 CN claimed
CN-116751115-A Preparation method of m-methoxychlorobenzyl chloride 苏州诚和医药化学有限公司 2023-09-15 CN claimed
EP-3183255-B1 SPIROPYRROLIDINES AS MDM2 INHIBITORS HUDSON BIOPHARMA INC (US) 2023-07-05 EP claimed
US-20220211602-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2022-07-07 US claimed
CN-110183371-B Preparation process of zafirlukast intermediate 南京医科大学 2022-06-14 CN claimed
EP-3946240-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL Henkel AG & Co. KGaA (DE) 2022-02-09 EP claimed
EP-2516479-A2 NEW INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS BASF Corporation (US) 2012-10-31 EP claimed
US-8211819-B2 Internal and external donor compounds for olefin polymerization catalysts BASF CORPORATION (US) 2012-07-03 US claimed
WO-2011106480-A2 INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS II BASF CORPORATION (US) 2011-09-01 WO claimed
US-20110207901-A1 INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS II BASF CATALYSTS LLC (US) 2011-08-25 US claimed
WO-2011084691-A2 NEW INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS BASF CORPORATION (US) 2011-07-14 WO claimed
US-20110152481-A1 Internal and external donor compounds for olefin polymerization catalysts BASF CATALYSTS LLC (US) 2011-06-23 US claimed
CN-101056628-A Ester derivatives and medicinal use thereof JAPAN TOBACCO INC (JP) 2007-10-17 CN claimed
EP-0153822-B1 METHOD FOR PREPARING CIS-BICYCLO(3.3.0)OCTYLIDENE DERIVATIVE SAGAMI CHEMICAL RESEARCH CENTER (JP) 1990-05-23 EP claimed
US-4632997-A HYDROGENATION WITH GROUP VIB METAL CARBONYL COMPLEX CATALYST; STEREOSPECIFIC SAGAMI CHEMICAL RESEARCH CENTER (JP) 1986-12-30 US claimed
EP-0153822-A1 Method for preparing cis-bicyclo(3.3.0)octylidene derivative SAGAMI CHEMICAL RESEARCH CENTER (JP) 1985-09-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240292836-A1 AGENTS FOR REPELLING, KNOCKING DOWN, AND/OR KILLING BLOOD-SUCKING ARTHROPODS AND USES THEREOF L3MBTL4, L3MBTL3, L3MBTL1 SMN1; SMN2 962/4885TP53 3259/4885CES2 262/4885
US-20220211602-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL KRT18, CCNA1, CCNA2 SMN1; SMN2 2729/4885TP53 230/4885CES2 4416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.